Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Low-cost videomicroscopes might not be reliable for examining scalp disorders compared to standard methods.

Low-cost videomicroscopy may not be reliable for diagnosing hair loss compared to standard videodermatoscopy.

Low-cost videomicroscopes may not be reliable for diagnosing scalp disorders, smartphones could be reasonable for teledermatology, and U.S. residency programs need more teledermatology training.

Hormones and signaling pathways control sebaceous gland function and could help treat acne.

Hydrangea serrata extract may promote hair growth and improve hair health.

Collagen from tilapia scales may improve hair and skin health by reducing stress and inflammation and encouraging hair growth.

Melatonin, the sleep hormone, can help treat skin conditions like dermatitis, hyperpigmentation, and scalp disorders, and may also aid in skin aging prevention and regeneration. However, it's not recommended for asthma due to its pro-inflammatory effect.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Natural small molecules can help treat diseases by activating or inhibiting the Wnt pathway.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.

A rare skin cancer caused hair loss and spread, needing multiple treatments.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

β-interferon injections for melanoma can cause excessive hair growth at the injection sites.

Mesotherapy might improve hair growth, but more research is needed to confirm its safety and effectiveness.

Some blood pressure medications are linked to a higher risk of skin cancer.

High dose rate electronic brachytherapy is an effective and safe non-surgical treatment for nonmelanoma skin cancer with good cosmetic results after three years.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.